{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T14:37:07Z","timestamp":1790087827777,"version":"4.0.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["NSTC 112-2629-B-182A-001"],"award-info":[{"award-number":["NSTC 112-2629-B-182A-001"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005795","name":"Chang Gung Memorial Hospital, Linkou","doi-asserted-by":"publisher","award":["CMRPG3N0721\/2"],"award-info":[{"award-number":["CMRPG3N0721\/2"]}],"id":[{"id":"10.13039\/501100005795","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Gene Ther"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1038\/s41417-026-01039-2","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T13:15:00Z","timestamp":1778246100000},"page":"588-600","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Dual PI3K\/AKT\/mTOR and CDK4\/6 inhibition suppresses survivin to overcome uterine dedifferentiated endometrial carcinoma"],"prefix":"10.1038","volume":"33","author":[{"given":"Yun-Hsin","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Lung","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3834-2754","authenticated-orcid":false,"given":"Angel","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chyong-Huey","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Ming","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Shien","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Chih","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1256-7018","authenticated-orcid":false,"given":"Chiao-Yun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,8]]},"reference":[{"key":"1039_CR1","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1056\/NEJMra1514010","volume":"383","author":"KH Lu","year":"2020","unstructured":"Lu KH, Broaddus RR. Endometrial cancer. N Engl J Med. 2020;383:2053\u201364.","journal-title":"N Engl J Med"},{"key":"1039_CR2","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1136\/ijgc-2019-000465","volume":"29","author":"M AlHilli","year":"2019","unstructured":"AlHilli M, Elson P, Rybicki L, Amarnath S, Yang B, Michener CM, et al. Undifferentiated endometrial carcinoma: a National Cancer Database analysis of prognostic factors and treatment outcomes. Int J Gynecol Cancer. 2019;29:1126\u201333.","journal-title":"Int J Gynecol Cancer"},{"key":"1039_CR3","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1111\/his.14186","volume":"77","author":"A Busca","year":"2020","unstructured":"Busca A, Parra-Herran C, Nofech-Mozes S, Djordjevic B, Ismiil N, Cesari M, et al. Undifferentiated endometrial carcinoma arising in the background of high-grade endometrial carcinoma\u2014expanding the definition of dedifferentiated endometrial carcinoma. Histopathology. 2020;77:769\u201380.","journal-title":"Histopathology"},{"key":"1039_CR4","first-page":"1008","volume":"7","author":"R Yokomizo","year":"2017","unstructured":"Yokomizo R, Yamada K, Iida Y, Kiyokawa T, Ueda K, Saito M, et al. Dedifferentiated endometrial carcinoma: a report of three cases and review of the literature. Mol Clin Oncol. 2017;7:1008\u201312.","journal-title":"Mol Clin Oncol"},{"key":"1039_CR5","doi-asserted-by":"publisher","first-page":"3794.","DOI":"10.3390\/ijms23073794","volume":"23","author":"HJ Tung","year":"2022","unstructured":"Tung HJ, Wu RC, Lin CY, Lai CH. Rare subtype of endometrial cancer: undifferentiated\/dedifferentiated endometrial carcinoma, from genetic aspects to clinical practice. Int J Mol Sci. 2022;23:3794.","journal-title":"Int J Mol Sci"},{"key":"1039_CR6","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.humpath.2022.10.003","volume":"130","author":"D Korentzelos","year":"2022","unstructured":"Korentzelos D, Elishaev E, Zhao C, Jones MW, Soong TR, Lesnock J, et al. ARID1A, BRG1, and INI1 deficiency in undifferentiated and dedifferentiated endometrial carcinoma: a clinicopathologic, immunohistochemical, and next-generation sequencing analysis of a case series from a single institution. Hum Pathol. 2022;130:65\u201378.","journal-title":"Hum Pathol"},{"key":"1039_CR7","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2174\/1389450114666140106100909","volume":"15","author":"LM Dillon","year":"2014","unstructured":"Dillon LM, Miller TW. Therapeutic targeting of cancers with loss of PTEN function. Curr Drug Targets. 2014;15:65\u201379.","journal-title":"Curr Drug Targets"},{"key":"1039_CR8","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/path.4896","volume":"242","author":"MA Dosil","year":"2017","unstructured":"Dosil MA, Mirantes C, Eritja N, Felip I, Navaridas R, Gatius S, et al. Palbociclib has antitumour effects on Pten-deficient endometrial neoplasias. J Pathol. 2017;242:152\u201364.","journal-title":"J Pathol"},{"key":"1039_CR9","first-page":"710","volume":"6","author":"C Mirantes","year":"2013","unstructured":"Mirantes C, Eritja N, Dosil MA, Santacana M, Pallares J, Gatius S, et al. An inducible knockout mouse to model the cell-autonomous role of PTEN in initiating endometrial, prostate and thyroid neoplasias. Dis Model Mech. 2013;6:710\u201320.","journal-title":"Dis Model Mech"},{"key":"1039_CR10","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.ygyno.2016.04.003","volume":"141","author":"AH Chuwa","year":"2016","unstructured":"Chuwa AH, Sone K, Oda K, Ikeda Y, Fukuda T, Wada-Hiraike O, et al. Significance of survivin as a prognostic factor and a therapeutic target in endometrial cancer. Gynecol Oncol. 2016;141:564\u20139.","journal-title":"Gynecol Oncol"},{"key":"1039_CR11","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.bbrc.2010.03.165","volume":"395","author":"P Zhao","year":"2010","unstructured":"Zhao P, Meng Q, Liu LZ, You YP, Liu N, Jiang BH. Regulation of survivin by PI3K\/Akt\/p70S6K1 pathway. Biochem Biophys Res Commun. 2010;395:219\u201324.","journal-title":"Biochem Biophys Res Commun"},{"key":"1039_CR12","doi-asserted-by":"publisher","first-page":"314","DOI":"10.7150\/jca.13332","volume":"7","author":"X Chen","year":"2016","unstructured":"Chen X, Duan N, Zhang C, Zhang W. Survivin and tumorigenesis: molecular mechanisms and therapeutic strategies. J Cancer. 2016;7:314\u201323.","journal-title":"J Cancer"},{"key":"1039_CR13","doi-asserted-by":"publisher","first-page":"53087","DOI":"10.1074\/jbc.M410254200","volume":"279","author":"W Chien","year":"2004","unstructured":"Chien W, Kumagai T, Miller CW, Desmond JC, Frank JM, Said JW, et al. Cyr61 suppresses growth of human endometrial cancer cells. J Biol Chem. 2004;279:53087\u201396.","journal-title":"J Biol Chem"},{"key":"1039_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-023-10892-5","volume":"23","author":"JSF Hameed","year":"2023","unstructured":"Hameed JSF, Devarajan A, MS DP, Bhattacharyya A, Shirude MB, Dutta D, et al. PTEN-negative endometrial cancer cells protect their genome through enhanced DDB2 expression associated with augmented nucleotide excision repair. BMC Cancer. 2023;23:399.","journal-title":"BMC Cancer"},{"key":"1039_CR15","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/0090-8258(84)90080-5","volume":"17","author":"GS Richardson","year":"1984","unstructured":"Richardson GS, Dickersin GR, Atkins L, MacLaughlin DT, Raam S, Merk LP, et al. KLE: a cell line with a defective estrogen receptor derived from undifferentiated endometrial cancer. Gynecol Oncol. 1984;17:213\u201330.","journal-title":"Gynecol Oncol"},{"key":"1039_CR16","doi-asserted-by":"publisher","first-page":"3533","DOI":"10.1158\/1078-0432.CCR-12-3815","volume":"19","author":"B Weigelt","year":"2013","unstructured":"Weigelt B, Warne PH, Lambros MB, Reis-Filho JS, Downward J. PI3K pathway dependencies in endometrioid endometrial cancer cell lines. Clin Cancer Res. 2013;19:3533\u201344.","journal-title":"Clin Cancer Res"},{"key":"1039_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-025-15053-4","volume":"25","author":"CY Huang","year":"2025","unstructured":"Huang CY, Chao A, Lin CY, Rozen SG, Chao AS, Chang CB, et al. Distinct genomic subgroups and mutational patterns in undifferentiated\/dedifferentiated endometrial carcinoma. BMC Cancer. 2025;25:1540.","journal-title":"BMC Cancer"},{"key":"1039_CR18","doi-asserted-by":"publisher","first-page":"5962.","DOI":"10.3390\/cancers13235962","volume":"13","author":"CY Lin","year":"2021","unstructured":"Lin CY, Wu RC, Huang CY, Lai CH, Chao AS, Li HP, et al. A patient-derived xenograft model of dedifferentiated endometrial carcinoma: a proof-of-concept study for the identification of new molecularly informed treatment approaches. Cancers. 2021;13:5962.","journal-title":"Cancers"},{"key":"1039_CR19","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1038\/s41591-019-0422-6","volume":"25","author":"O Kopper","year":"2019","unstructured":"Kopper O, de Witte CJ, Lohmussaar K, Valle-Inclan JE, Hami N, Kester L, et al. An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity. Nat Med. 2019;25:838\u201349.","journal-title":"Nat Med"},{"key":"1039_CR20","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","volume":"70","author":"TC Chou","year":"2010","unstructured":"Chou TC. Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res. 2010;70:440\u20136.","journal-title":"Cancer Res"},{"key":"1039_CR21","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1097\/IGC.0000000000001061","volume":"27","author":"E Girda","year":"2017","unstructured":"Girda E, Huang EC, Leiserowitz GS, Smith LH. The use of endometrial cancer patient-derived organoid culture for drug sensitivity testing is feasible. Int J Gynecol Cancer. 2017;27:1701\u20137.","journal-title":"Int J Gynecol Cancer"},{"key":"1039_CR22","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.1080\/15548627.2023.2239633","volume":"19","author":"CY Lin","year":"2023","unstructured":"Lin CY, Wu KY, Chi LM, Tang YH, Huang HJ, Lai CH, et al. Starvation-inactivated MTOR triggers cell migration via a ULK1-SH3PXD2A\/TKS5-MMP14 pathway in ovarian carcinoma. Autophagy. 2023;19:3151\u201368.","journal-title":"Autophagy"},{"key":"1039_CR23","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1007\/s00109-018-1699-5","volume":"96","author":"A Chao","year":"2018","unstructured":"Chao A, Lin CY, Wu RC, Lee YS, Lee LY, Tsai CL, et al. The combination of everolimus and terameprocol exerts synergistic antiproliferative effects in endometrial cancer: molecular role of insulin-like growth factor binding protein 2. J Mol Med. 2018;96:1251\u201366.","journal-title":"J Mol Med"},{"key":"1039_CR24","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.anndiagpath.2019.01.001","volume":"39","author":"X Zhang","year":"2019","unstructured":"Zhang X, Yu M. Undifferentiated endometrial carcinoma: a selected immunohistochemical panel including PAX-8 and E-cadherin for aiding distinction from other endometrial carcinomas. Ann Diagn Pathol. 2019;39:36\u201341.","journal-title":"Ann Diagn Pathol"},{"key":"1039_CR25","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s11033-013-2856-0","volume":"41","author":"R Boidot","year":"2014","unstructured":"Boidot R, Vegran F, Lizard-Nacol S. Transcriptional regulation of the survivin gene. Mol Biol Rep. 2014;41:233\u201340.","journal-title":"Mol Biol Rep"},{"key":"1039_CR26","doi-asserted-by":"publisher","first-page":"R85","DOI":"10.1530\/ERC-15-0218","volume":"23","author":"A Makker","year":"2016","unstructured":"Makker A, Goel MM. Tumor progression, metastasis, and modulators of epithelial-mesenchymal transition in endometrioid endometrial carcinoma: an update. Endocr Relat Cancer. 2016;23:R85\u2013R111.","journal-title":"Endocr Relat Cancer"},{"key":"1039_CR27","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1042\/bj3440305","volume":"344","author":"F Li","year":"1999","unstructured":"Li F, Altieri DC. Transcriptional analysis of human survivin gene expression. Biochem J. 1999;344:305\u201311.","journal-title":"Biochem J"},{"key":"1039_CR28","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s10549-015-3282-x","volume":"149","author":"SA Hurvitz","year":"2015","unstructured":"Hurvitz SA, Kalous O, Conklin D, Desai AJ, Dering J, Anderson L, et al. In vitro activity of the mTOR inhibitor everolimus, in a large panel of breast cancer cell lines and analysis for predictors of response. Breast Cancer Res Treat. 2015;149:669\u201380.","journal-title":"Breast Cancer Res Treat"},{"key":"1039_CR29","doi-asserted-by":"crossref","unstructured":"Finn RS, Dering J, Conklin D, Kalous O, Cohen DJ, Desai AJ, et al. PD 0332991, a selective cyclin D kinase 4\/6 inhibitor, preferentially inhibits the proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro. Breast Cancer Res 2009;11:R77.","DOI":"10.1186\/bcr2419"},{"key":"1039_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04565-7","volume":"13","author":"S Liu","year":"2022","unstructured":"Liu S, Wang W, Ning Y, Zheng H, Zhan Y, Wang H, et al. Exosome-mediated miR-7-5p delivery enhances the anticancer effect of Everolimus via blocking MNK\/eIF4E axis in non-small cell lung cancer. Cell Death Dis. 2022;13:129.","journal-title":"Cell Death Dis"},{"key":"1039_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-02980-2","volume":"11","author":"W Ji","year":"2020","unstructured":"Ji W, Zhang W, Wang X, Shi Y, Yang F, Xie H, et al. c-myc regulates the sensitivity of breast cancer cells to palbociclib via c-myc\/miR-29b-3p\/CDK6 axis. Cell Death Dis. 2020;11:760.","journal-title":"Cell Death Dis"},{"key":"1039_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/or.2024.1444008","volume":"18","author":"AH Chuwa","year":"2024","unstructured":"Chuwa AH, Mvunta DH. Prognostic and clinicopathological significance of survivin in gynecological cancer. Oncol Rev. 2024;18:1444008.","journal-title":"Oncol Rev"},{"key":"1039_CR33","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.3892\/ol.2020.11690","volume":"20","author":"A Stavropoulos","year":"2020","unstructured":"Stavropoulos A, Varras M, Vasilakaki T, Varra VK, Varra FN, Tsavari A, et al. Expression of anti-apoptotic protein survivin in human endometrial carcinoma: Clinical and pathological associations as a separate factor and in combination with concomitant PTEN and p53 expression. Oncol Lett. 2020;20:1033\u201354.","journal-title":"Oncol Lett"}],"container-title":["Cancer Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41417-026-01039-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41417-026-01039-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41417-026-01039-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T05:35:42Z","timestamp":1783920942000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41417-026-01039-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["1039"],"URL":"https:\/\/doi.org\/10.1038\/s41417-026-01039-2","relation":{},"ISSN":["0929-1903","1476-5500"],"issn-type":[{"value":"0929-1903","type":"print"},{"value":"1476-5500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"31 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Institutional Review Board of Linkou Chang Gung Memorial Hospital, Taiwan (IRB approval numbers: 201801202B0, 201801840B0, and 202201930B0), and written informed consent was obtained from all participants for the use of their clinical data and tissue samples.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}